Fig. 3From: Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and responseAssociation of changes in gene expression between pretreatment and residual tumors (TS − T1) and recurrence-free survival (RFS). a Scatterplot showing the expression of a representative interferon signaling gene, IFIH1, at TS and T1, with the color of the points indicating outcome (red = no recurrence; blue = recurrence). The diagonal line represents no change in gene expression levels (T1 = TS). The length of the vertical lines between points and the diagonal line represents the magnitude of expression change from T1 to TS. Kaplan-Meier analysis of RFS among patients with high (top tertile: blue) or low expression (red) levels of IFIH1 at T1 (b), at TS (c) and the change in gene expression between two time points (TS − T1) (d)Back to article page